FY25 Guidance Upgrade and Appointment of CFO
Filed with ASX · · 2 pages · English
In the deck
Earlier from Somnomed
- Rest Assure - US Food and Drug Authority (FDA) Update
- Investor Presentation
- FY24 Preliminary Report and FY25 Guidance
- Preliminary Final Report
- Completion of retail component of Entitlement Offer
Later from Somnomed
- Investor Presentation AGM
- AGM Chairman & co-CEO addresses
- FY25 Guidance Update and Quarterly Report
- Quarterly Appendix 4C Cash Flow Report
- FY25 Half Year Results
Follow Somnomed into a list and get an email when it puts out news.
Follow Somnomed